Map Out Your Business Exit Strategy


The global beauty and personal care industry is in a state of dramatic transformation, driven by a powerful wave of portfolio restructuring. Across the sector, companies are embracing the art of the exit—selling assets, rationalizing operations, and streamlining product lines not as a retreat, but as a strategic move to sharpen focus for future growth.

This shift is playing out on multiple fronts, from geographic expansion to product innovation. Multinational giants are reassessing their holdings, making tough calls to concentrate resources where the long-term potential is strongest. For instance, Reckitt recently finalized the sale of its Russian hygiene business to Arnest, marking another significant step in restructuring multinational consumer businesses across borders.

The reins of ownership are also being redrawn. In China, the dynamic among beauty groups continues to evolve as Beijing Liyuan is set to exit its cosmetics joint venture with Shiseido, reflecting a wider strategy by international beauty players to optimize their market strategies in increasingly competitive arenas.

Established leaders are simultaneously focusing on domestic efficiency to fuel global ambitions. Amorepacific, for example, is reshaping its domestic asset portfolio to better support its international growth strategy, planning moves such as selling manufacturing plants to improve capital efficiency and redirect funds toward higher-priority opportunities.

Innovation demands a similar discipline. Even highly recognizable hero products are subject to evolution. Fenty Beauty, recognizing the need to chase next-generation innovations, is retiring established lines like the Pro Filt’r Foundation to make room for exciting new launches, demonstrating that pruning existing assortments can be the fastest route to breakthrough creativity.

This focus extends to retailers and corporate real estate. Retailers are also making deliberate choices about their inventory, with decisions being influenced by external factors; Superdrug removed certain products amid scrutiny over alleged links to geopolitical events, illustrating how reputational considerations now heavily dictate buying strategies.

On the institutional side, divestments represent successful value creation. Investors are realizing significant returns by exiting successful businesses, reinforcing confidence in the intersection of beauty, healthcare, and advanced skincare. This trend is seen in the exit of Galderma by EQT-led investors, which demonstrated substantial gains in the science-led dermatology space.

Even physical assets are under review. Companies like Mary Kay are exploring the sale of global headquarters as they evaluate capital efficiency and the strategic value of their real estate holdings. This highlights a broader corporate trend where even long-held physical assets are scrutinized for their ability to support future objectives.

Ultimately, these actions—whether divesting business units, retiring products, or restructuring operations—demonstrate an industry becoming incredibly comfortable with the process of optimization. Rather than signaling retreat, these moves are emerging as essential tools for sharpening strategic focus. Knowing what to sell, close, retire, or restructure is proving just as important today as knowing where to invest next.

You may also like: